Gene Query: CD300A

Dataset Description Geneva Score
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 66.25
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 51.0
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 42.13
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 36.67
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 31.74
RNA-Seq from human ILC transitional populations 31.74
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 28.02
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 28.02
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 26.65
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 26.65
Transcriptome analysis of SKI knock-out in HL60 cells 25.92
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 25.92
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 25.5
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 25.06
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 24.55
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 24.17
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 24.01
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 24.0
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 23.71
Ro60-knockout cells 23.7
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 22.88
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 22.8
The role of FAM46C in myeloma cells [sequencing] 21.8
The role of FAM46C in myeloma cells 21.8
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 21.61
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 21.61
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 21.31
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 21.31
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 20.77
A novel target of EZH1/2 for treatment of mantle cell lymphoma 19.64
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 19.59
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 19.26
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 18.04
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 17.92
Characterization of human ILC2 subsets 17.83
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 17.25
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 16.8
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 16.1
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 16.07
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 15.69
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 15.67
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 15.65
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 15.38
Tpl-2 and MEK small molecule inhibitors 15.03
Tpl-2 small molecule project 15.03
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 14.84
Transcriptome-wide identification of CELF2 functional targets in T cells 14.53
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 14.3
Global analysis of alternative splicing regulated by RBM10 13.95
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 13.95
Gene expression changes associated with resistance to tagraxofusp (SL-401) 13.88
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 13.33
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 12.86
Landscape of H3K4me3 in human CD19 cells 12.6
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 12.39
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 12.39
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 12.23
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 12.07
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 11.92
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 11.59
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 11.56
Human neutrophil genome during PMA- and E. coli encounter-induced activation 11.56
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 11.54
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 11.22
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 11.17
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 11.17
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 11.13
SRSF2 mutations impair hematopoiesis and alter exon recognition 10.86
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 10.63
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 10.63
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 10.63
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 10.63
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 10.48
Transcriptional profile in human S. haematobium infection 10.43
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 10.4
Proliferation-correlated expression 10.34
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.27
RNA-seq of stable and unstable section of human atherosclerotic plaques 9.92
mRNA expression profile of Lymphocytes by high-throuput sequencing 9.88
Transcriptome of activated human and mouse MAIT cells 9.75
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 9.69
Transcriptional profiling of microglia; current state of the art and future perspectives 9.56
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 9.52
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 9.42
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.29
CircRNAome diversity in human mature B-cells, T-cells and monocytes 9.29
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 9.28
Intron retention induced by microsatellite expansions as a disease biomarker. 9.25
RNAseq of T-ALL upon long non coding rna purturbation 8.93
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 8.91
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 8.87
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 8.87
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 8.86
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 8.86
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 8.73
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 8.63
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 8.5
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 8.46
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 8.27
Human T-cell lymphoblastic lymphoma samples and control thymuses 8.17
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 8.17
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 8.0
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 7.97
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.91
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 7.86
Aging-associated patterns in the expression of human endogenous retroviruses 7.82
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 7.76
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 7.74
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.58
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 7.57
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.5
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 7.38
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 7.38
RNA-Seq in neutrophils from Antiphospholipid Syndrome 7.29
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.28
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 7.24
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 7.24
RNA-seq analysis of AML cells in response to ASLAN003 7.13
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 7.04
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 7.04
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.01
BCL11B 6.79
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 6.74
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 6.72
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 6.71
mRNA expression profile of Lymphocytes 6.62
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.56
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.45
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.45
Microglia innatly develop within cerebral organoids 6.41
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 6.11
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 6.1
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 6.1
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 6.03
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.94
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.94
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.89
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.86
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 5.82
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 5.76
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 5.69
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.64
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.64
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 5.62
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.57
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 5.51
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 5.49
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 5.31
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 5.29
Identification of renal resident macrophages across species 5.18
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.16
Transcriptome analysis of virus infected tissues 5.13
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.93
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 4.92
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 4.81
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 4.81
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 4.81
The evolution of N6-methyladenosine in primates 4.79
RNA-seq of CD33 KO and control HSPCs 4.76
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 4.74
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.74
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 4.66
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 4.55
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 4.5
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.48
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 4.47
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 4.45
naive T cell heterogeneity after neonatal thymectomy 4.39
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 4.32
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 4.32
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.25
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.2
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 4.2
Single cell transcriptome of peritoneal cells 4.16
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 4.14
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 4.11
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 4.11
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 4.07
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 4.03
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 4.03
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 4.01
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.95
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 3.94
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 3.92
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 3.92
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 3.9
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.88
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 3.88
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.85
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.84
The Genetic Landscape of Diamond-Blackfan Anemia 3.81
Generation and functional characterization of MDSC-like cells 3.8
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.78
Leucegene: ALL sequencing 3.77
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.76
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 3.74
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 3.74
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.71
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.7
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.66
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.64
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.64
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 3.61
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.58
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.53
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.49
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 3.48
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 3.45
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.45
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 3.43
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 3.43
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 3.42
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.41
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.4
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.36
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 3.35
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.31
A map of gene expression in neutrophil-like cell lines 3.31
Effects of rFVIIIFc on human macrophages 3.3
Reprogrammed myeloid cell transcriptomes in NSCLC 3.26
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 3.25
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.2
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 3.16
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 3.14
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.13
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 3.13
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.12
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 3.09
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.04
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 3.04
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.01
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.94
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.94
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.91
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.88
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.87
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 2.84
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 2.84
Transcriptomic profiling of human peripheral blood-derived mast cells 2.82
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.82
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.8
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.77
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.75
Gene expression signatures of innate lymphoid cells from human blood 2.74
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.71
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 2.7
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 2.66
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 2.66
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.61
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 2.61
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.58
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 2.58
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 2.57
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 2.57
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.57
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.49
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.49
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.45
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.44
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.42
Identification of renal resident macrophages across species [C1] 2.39
Landscape and variation of RNA secondary structure across the human transcriptome 2.39
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.38
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.37
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.36
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 2.35
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.32
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.28
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 2.27
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.27
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.26
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 2.25
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 2.25
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.24
Transcriptome wide analysis of classically and alternatively activated macrophages 2.24
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 2.22
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 2.21
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 2.21
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.2
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 2.18
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.17
RNA-Seq and expression data from human adipose tissue 2.17
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 2.14
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 2.13
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.11
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 2.09
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 2.09
Stem and effector CD8 T-cells from human cancers 2.09
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.08
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.07
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 2.06
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.06
CD86 regulates a pro-survival signal in myeloma cells 2.05
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.02
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.01
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.01
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 2.01
Dynamic 3D chromosomal landscapes in acute leukemia 2.01
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.0
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.0
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 2.0
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.99
Short and Long RNA sequencing of human mature erythrocytes 1.99
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.98
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.97
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.97
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.95
The comparison of high-throughput single-cell RNA-seq methods 1.94
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.92
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.91
Targeting MTHFD2 in Acute Myeloid Leukemia 1.9
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 1.89
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 1.89
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.86
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.86
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.86
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 1.85
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 1.85
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.85
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.85
Total RNA sequencing of WT intestinal orgaonids. 1.83
Macrophage Ad5f35 M2 Challenge 1.82
Transcriptome analysis of CNS leukemia 1.81
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.79
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.76
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 1.75
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.74
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.74
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.74
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 1.74
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.74
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.73
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.7
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.69
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.68
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 1.67
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.67
RNA-seq of Single-Cell Genotyping of Transcriptomes 1.61
Single-Cell Genotyping of Transcriptomes 1.61
Specific molecular signatures underlie response to decitabine in CMML 1.61
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.61
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.59
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.58
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.52
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 1.52
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 1.52
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 1.51
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.5
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.48
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 1.46
RNA-seq in endometrial stromal tumors 1.43
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 1.42
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.42
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.42
Leucegene: AML sequencing (part 6) 1.41
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 1.4
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.37
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.37
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.34
Unique features and clinical importance of acute alloreactive immune responses 1.34
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 1.31
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 1.28
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 1.25
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 1.24
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.22
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.21
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.21
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.21
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.19
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 1.17
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.17
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.17
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.14
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.14
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.09
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.08
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.07
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 1.06
Hepatosplenic T cell lymphoma 1.06
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.06
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.04
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.04
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 1.03
NAPRT activation of macrophages 1.01
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.0
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.99
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.99
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 0.98
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.98
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.97
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.97
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.96
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.87
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.86
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.86
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 0.84
Transcriptomes in healthy and CHB fetal hearts 0.83
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.82
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.81
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.8
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.8
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.79
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.78
quanTIseq: quantifying immune contexture of human tumors 0.78
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.78
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.78
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.77
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.77
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.76
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.74
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 0.72
The Glioma-Infiltrating T Cell Receptor Repertoire 0.72
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.71
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.7
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 0.7
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.7
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.69
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.68
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.67
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 0.65
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.65
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 0.63
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 0.63
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 0.62
Single-cell analysis of adult human ovary using 10X genomics 0.6
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.6
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.56
A single cell reference map for human blood and tissue T cell activation 0.56
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.55
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.55
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 0.55
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.54
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.51
MHC Transcriptomic landscape at haplotype-specific resolution 0.49
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.46
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.45
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.44
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.44
An optimization system for isolating and sequencing of single human colon cancer cells 0.43
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.42
Human optic chiasm from healthy controls and multiple sclerosis patients 0.41
Multiple sclerosis and EAE 0.41
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.41
Dysregulated immune system networks in war veterans with PTSD 0.38
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.38
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.38
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.37
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.36
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.36
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.36
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.33
Transcriptome analysis of peripheral blood monocytes 0.32
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.31
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.31
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.31
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.31
LncRNA expression profiling of ischemic stroke patients 0.29
Identification of long noncoding RNAs in T-ALL cell lines 0.28
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.27
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 0.23
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.23
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.22
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.2
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.19
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.19
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.18
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.18
The role of m6A/m-RNA methylation in stress response regulation 0.18
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.17
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 0.16
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.16
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.16
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.15
Macrophage Ad5f35 PhenoMap 0.15
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.14
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.11
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.11
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.1
Analyses of T-ALL (COG study) 0.1
RNA sequencing of T-ALL (COG study) 0.1
Clinker: visualizing fusion genes detected in RNA-seq data 0.09
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.09
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.09
MAIT cell RNA sequencing 0.08
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.08
Transcriptomes of oxLDL exposed trained monocytes 0.08
oxLDL exposed trained monocytes 0.08
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.08
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.07
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.07
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.06
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.05
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.05
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.04
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 0.03
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.03
Molecular analysis of renal cell carcinoma with unclassfied histology 0.02
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.02
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.02
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation